InfoMedics launches doctor-patient feedback programs

InfoMedics, Inc. has implemented patient feedback programs to improve doctor-patient communication and enhance the impact of marketing programs for biopharmaceutical brands through every phase and challenge of the product life cycle: disease state awareness, early experience, branded launch campaign, growth, mature product and patient compliance.

InfoMedics' doctor-patient feedback programs close the loop between patients and doctors by documenting patients' experiences with prescription drugs and medical devices by providing real-time data to each patient's prescribing doctor.

This information lets doctors know when drugs are working well for their patients and also alerts them to potential issues -- such as a risk of non-adherence -- that can be used as talking points during the next office visit. The process also includes an array of patient education tools, and provides physicians with unique insights about how the drugs they prescribe are affecting their patients.

"With decreasing budgets and increasing regulatory and public scrutiny, pharmaceutical companies need to be more strategic than ever in marketing their brands," said Gene Guselli, president and CEO of InfoMedics. "Over the last 14 years, our patient feedback solutions have consistently proven that they can be applied to tackle a challenge at any point in a product's life cycle and result in positive improvements in the communication between patients and their doctors as well as benefits to the pharmaceutical brand."

Source:

InfoMedics, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study provides insights into trends and disparities of neonatal infectious diseases in LMICs